Search Results 901-910 of 18632 for hepatitis

  1. Deflazacort (oral route) - Mayo Clinic

    Cushing's syndrome (adrenal gland problem) or; Diabetes or; Glaucoma or; Heart attack, recent or; Hepatitis B infection or; Hyperglycemia (high blood sugar) or ...

  2. Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer - Mayo Clinic

    Patient must be tested for hepatitis B within 28 days prior to randomization. Patient must not have active (chronic or acute) hepatitis B virus (HBV) infection.

  3. Expanding Liver Transplant Immunosuppression Minimization Via Everolimus - Mayo Clinic

    History of hepatitis B or C virus infection with detectable viral PCR at enrollment. 8. History of prior organ transplantation. (liver or other type) 9 ...

  4. Publications - Giovanni De Petris, M.D. - Mayo Clinic

    Fulminant hepatitis due to human adenovirus. Infection. 2014 Feb; 42 (1):105 ... Natural history of post-liver transplantation hepatitis C: A review of factors ...

  5. Health concerns for transgender people - Mayo Clinic

    Hepatitis. High blood pressure. High cholesterol. Osteoporosis. Prostate cancer. Your provider also may recommend screenings for: Mental health conditions ...

  6. Etigilimab and Nivolumab in Subjects With Locally Advanced or Metastatic Tumors - Mayo Clinic

    Active infections of HIV, hepatitis B, hepatitis C. Medical illness or abnormal laboratory finding that would, in the Study Investigator's judgement ...

  7. Targeting of Hepatic Stellate Cell PD-L1 To Inhibit Tumor Microenvironment and Cholangiocarcinoma - Mayo Clinic Research

    Hepatitis B-Associated Hepatocellular Carcinoma: Variation in Therapeutic Response Mediated by Viral Integration · Rab GTPases As Drivers of Lipid Droplet ...

  8. Tofacitinib (oral route) - Mayo Clinic

    May increase risk of developing infections. Heart or blood vessel disease or; Hepatitis B, history of or; Hepatitis C, history of or; Herpes zoster infection ...

  9. Elevate CLL R/R: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia - Mayo Clinic

    Subjects with hepatitis B core antibody positive who are surface antigen negative or who are hepatitis ... Those who are hepatitis B surface antigen positive or ...

  10. MDM2 Inhibitor AMG-232 and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma - Mayo Clinic

    Patients with known Positive Hepatitis B Surface Antigen (HepBsAg) (indicative of chronic Hepatitis B), positive Hepatitis total core antibody with ...